As of Sep 20
| +0.46 / +5.87%|
The 12 analysts offering 12-month price forecasts for Evolent Health Inc have a median target of 16.50, with a high estimate of 25.00 and a low estimate of 10.00. The median estimate represents a +98.80% increase from the last price of 8.30.
The current consensus among 13 polled investment analysts is to Buy stock in Evolent Health Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.